Hap Trading, LLC Bristol Myers Squibb CO Put Options Transaction History

Hap Trading, LLC

  • $840 Billion
  • Q2 2024

Put Options

25 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$40.25 - $52.99 $1.75 Million - $2.31 Million
43,500 New
43,500 $142 Million
Q3 2023

Nov 09, 2023
BUY
$57.89 - $64.73 $590,478 - $660,246
10,200 Added 94.44%
21,000 $1.22 Million
Q2 2023

Aug 11, 2023
SELL
$63.71 - $70.74 $70,081 - $77,814
-1,100 Reduced 9.24%
10,800 $690,000
Q1 2023

May 12, 2023
SELL
$65.71 - $74.53 $243,126 - $275,761
-3,700 Reduced 23.72%
11,900 $30,000
Q4 2022

Feb 14, 2023
SELL
$68.48 - $81.09 $486,208 - $575,739
-7,100 Reduced 31.28%
15,600 $34,000
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $650 - $384,200
5,000 Added 28.25%
22,700 $50,000
Q2 2022

Aug 12, 2022
SELL
$72.62 - $79.98 $1.99 Million - $2.19 Million
-27,400 Reduced 60.75%
17,700 $30,000
Q1 2022

May 12, 2022
SELL
$61.48 - $73.72 $129,108 - $154,812
-2,100 Reduced 4.45%
45,100 $29,000
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $841,991 - $981,564
15,700 Added 49.84%
47,200 $47,000
Q3 2021

Nov 10, 2021
BUY
$59.17 - $69.31 $136,091 - $159,413
2,300 Added 7.88%
31,500 $85,000
Q2 2021

Aug 11, 2021
SELL
$61.91 - $67.42 $507,662 - $552,844
-8,200 Reduced 21.93%
29,200 $27,000
Q1 2021

May 14, 2021
SELL
$59.34 - $66.74 $789,222 - $887,641
-13,300 Reduced 26.23%
37,400 $53,000
Q4 2020

Feb 16, 2021
SELL
$57.74 - $65.43 $1.51 Million - $1.71 Million
-26,100 Reduced 33.98%
50,700 $52,000
Q3 2020

Nov 13, 2020
SELL
$57.43 - $63.64 $24.3 Million - $26.9 Million
-423,000 Reduced 84.63%
76,800 $96,000
Q2 2020

Aug 10, 2020
BUY
$54.82 - $64.09 $23.1 Million - $26.9 Million
420,500 Added 530.26%
499,800 $226,000
Q1 2020

May 08, 2020
SELL
$46.4 - $67.43 $334,080 - $485,496
-7,200 Reduced 8.32%
79,300 $234,000
Q3 2019

Nov 12, 2019
BUY
$42.77 - $50.71 $538,902 - $638,946
12,600 Added 17.05%
86,500 $290,000
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $33.3 Million - $36.8 Million
-745,700 Reduced 90.98%
73,900 $524,000
Q1 2019

May 10, 2019
BUY
$45.12 - $53.8 $25.1 Million - $29.9 Million
555,400 Added 210.22%
819,600 $621,000
Q4 2018

Feb 12, 2019
BUY
$48.76 - $63.23 $2.09 Million - $2.71 Million
42,800 Added 19.33%
264,200 $403,000
Q3 2018

Nov 09, 2018
SELL
$55.19 - $62.25 $275,950 - $311,250
-5,000 Reduced 2.21%
221,400 $42,000
Q2 2018

Aug 13, 2018
BUY
$50.53 - $62.98 $591,201 - $736,866
11,700 Added 5.45%
226,400 $188,000
Q1 2018

May 11, 2018
SELL
$59.92 - $68.98 $24.1 Million - $27.8 Million
-403,000 Reduced 65.24%
214,700 $184,000
Q4 2017

Feb 09, 2018
BUY
$59.94 - $65.35 $33.7 Million - $36.7 Million
562,200 Added 1012.97%
617,700 $103,000
Q3 2017

Nov 08, 2017
BUY
$55.23 - $63.74 $3.07 Million - $3.54 Million
55,500
55,500 $49,000

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email